Could the concomitant use of beta blockers with bevacizumab improve survival in metastatic colon cancer?
Mehmet Zahid Koçak, Muhiddin Er, Muzaffer Uğraklı, Engin Hendem, Murat Araz, Melek Karakurt Eryılmaz, Mehmet Artaç
Topics & Concepts
BevacizumabConcomitantMedicineColorectal cancerBETA (programming language)OncologyInternal medicineCancerChemotherapyPharmacologyComputer scienceProgramming languageCancer, Stress, Anesthesia, and Immune ResponseInflammatory mediators and NSAID effectsCancer, Lipids, and Metabolism